semaglutide o tirzepatide vs Semaglutide: What You Need to Know FDA Ban on Compounded GLP-1

do not use if you have a history of severe gastrointestinal disease Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness)

Long-term data across 104 weeks indicates sustained weight reduction profiles without an early plateau

Some plans only cover GLP-1s for type 2 diabetes, so checking with your healthcare provider and insurer can help you make an informed, realistic decision

If you are exploring peptides beyond semaglutide, whether for weight loss , fat loss , or other goals, the same temperature management principles apply